Deakin University
Browse

File(s) not publicly available

Ascorbic acid supplementation improves postprandial glucose and blood pressure in people with Type 2 diabetes

Version 2 2024-06-04, 11:52
Version 1 2018-12-06, 10:58
conference contribution
posted on 2024-06-04, 11:52 authored by S Mason, Bodil RasmussenBodil Rasmussen, Glenn WadleyGlenn Wadley
The aim of the study was to investigate whether ascorbic acid (AA) supplementation improves postprandial glucose responses under free living conditions in people with type 2 diabetes (T2D). Thirty-one people with T2D (26 male, 5 female; aged 61.8 ± 6.8y; duration of diabetes 5.6 ± 4.6y [mean ± SD]) and stable glucose control (HbA1c 7.6 ± 0.7%) and blood pressure (SBP 139 ± 10; DBP 85 ± 9 mmHg) completed a randomized cross-over study involving 4 months of oral AA (2 x 500 mg/day) supplementation and 4 months of placebo supplementation (# ACTRN12616000276459). A minimum wash-out of 4 weeks separated treatments. Participants were affixed with continuous glucose monitors for 48h and consumed standardized meals pre and post supplementation. Intention to treat analyses were used to analyse data. Postprandial glucose area under the curve for 3.5h post meals (10.5h total) and the percent of day spent in hyperglycaemia (>10 mmol/l) were significantly lower by 31% and 11% (∼2.5h) after AA supplementation when compared to placebo, respectively (p<0.05). Significantly lower systolic (-6 mmHg) and diastolic (-4 mmHg) blood pressures were also found after AA supplementation compared to placebo. There were no effects of AA supplementation on percent of day spent in hypoglycaemia (<4 mmol/l), average 24h glucose or HbA1c. Treatments were well tolerated by participants, with no adverse effects reported. Capsule compliance was high for both treatments (AA: 93 ± 11%; placebo: 95 ± 7%). In summary, AA supplementation attenuated the daily post-prandial glucose response and the proportion of day spent in hyperglycaemia in people with T2D. AA also improved blood pressure in this group. This evidence collected under free-living conditions strengthens the argument for AA as a beneficial adjunct therapy to improve glycaemic control and cardio-metabolic health for people with T2D.

History

Location

Orlando, Florida

Start date

2018-06-22

End date

2018-06-26

Language

eng

Notes

Published in Diabetes 2018 Jul; 67 (Supplement 1)

Publication classification

E3 Extract of paper

Title of proceedings

78th Scientific Sessions, American Diabetes Association

Event

American Diabetes Association. Scientific Sessions (78th : 2018 : Orlando, Florida)

Publisher

American Diabetes Association

Place of publication

[Orlando, Florida]

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC